Ketamine Bladder Damage: What K-Cramps Actually Mean

K-cramps are not a hangover or a cramp in the ordinary sense. They are a sign that your bladder is actively being damaged.

Ketamine-induced cystitis, also called ketamine uropathy, is regular use destroying the lining of the bladder and, in severe cases, the ureters and kidneys. It can be permanent. At the worst end, people have needed their bladder surgically removed, or ended up on dialysis.

This is not a fringe claim

Shahani described it first in 2007: nine daily users with sterile bladder inflammation, brutal urgency and frequency, thickened bladder walls on CT, and no response to UTI treatment, because none of it was ever bacterial. A Hong Kong series the following year took that to 59 patients and mapped the full range, from early cystitis through to contracted, scarred bladders and secondary kidney damage.

The largest picture comes from a 2022 systematic review and meta-analysis pooling 45 studies and 4,921 patients. Urinary frequency appeared in 77.1%, urgency in 69.9%, suprapubic pain (the k-cramps) in 60.4%, and hydronephrosis, meaning kidney swelling from blocked drainage, in 30.2%. A second 2022 review put the risk of cystitis symptoms in regular users at 3 to 4 times baseline, and found that stopping early is the most effective intervention anyone has measured.

This was long assumed to be a purely recreational problem. Then a 2024 case report documented it in a patient receiving therapeutic ketamine for treatment-resistant depression. The risk at therapeutic doses looks much lower. It is not zero.

Norketamine is what sits against your bladder

Whatever route you take it by, your liver converts ketamine to norketamine, the primary metabolite, and norketamine leaves in your urine, sitting in concentrated form directly against the bladder lining. The damage is not from the high. It is from what passes through afterward.

A 2015 pathophysiology review laid out several overlapping pathways. Norketamine strips the protective glycosaminoglycan layer off the lining, removing its barrier function. Metabolites activate sensory nerve fibers in the bladder wall and set off a persistent inflammatory cascade. There is an IgE-mediated component too, an allergic-looking response with mast cell degranulation in bladder tissue. And chronic inflammation lays down scar tissue, which permanently shrinks capacity.

The endpoint is a small, rigid, fibrotic bladder that holds very little and hurts nearly all the time. In a series of 14 people whose cystitis was severe enough to require bladder reconstruction surgery, mean bladder capacity before surgery was 50.9 mL, against a normal 400 to 600 mL. Read that number for what it is. Those were people referred for surgery after at least a year of failed conservative treatment, the most severe end of the spectrum, not typical users.

Where you are on the spectrum

This is the part that decides whether you can still recover.

Stage 1, early, reversible. More frequent and more urgent urination, mild burning. Often resolves within weeks to months of stopping.

Stage 2, active cystitis, potentially reversible. K-cramps, meaning sharp cramping pain above the pubic bone. Visible blood in urine. Needing to urinate every 15 to 30 minutes. Recovery is possible, slower, and may need medical support.

Stage 3, contracted bladder and upper tract involvement, often irreversible. Severely reduced bladder capacity, ureteral stenosis meaning narrowing of the tubes connecting kidneys to bladder, hydronephrosis, and renal failure in the worst cases. Surgery may be on the table, up to and including cystectomy, removal of the bladder.

K-cramps during or after use are a stage 2 signal. Keep using from there and stage 3 is the direction of travel.

What to do if this is you

1. Stop, or cut down hard. Cessation is the only intervention with consistent evidence behind it. Everything else is damage control.
2. See a urologist, not just a GP. A general practice visit often ends in antibiotics for a presumed UTI, which will do nothing, because this is not bacterial. You need cystoscopy and probably imaging. Tell them about the ketamine. They cannot help you without it.
3. Do not accept “drink more water.” That is UTI advice. This needs anticholinergics for urgency, NSAIDs for pain, and sometimes intravesical treatments such as sodium hyaluronate or chondroitin sulfate to help rebuild the urothelial barrier.
4. Rule out the upper tract. Months of symptoms means asking for a renal ultrasound or CT to check for hydronephrosis. Caught early it can sometimes be managed. Caught late, it may not.

Who ends up here

Daily or near-daily use is the biggest risk factor in every study. Heavier doses put more norketamine in the urine and long duration drives the fibrosis, so cumulative exposure matters as much as any single night. Damage has been documented in daily users taking as little as 1 to 2 g a day for months. Every route carries risk; intranasal use may concentrate more ketamine in urine than IV, though that is not definitively established. Most people in the literature started in their teens or early twenties.

Occasional use, once a month or less, has not been associated with this condition in the published work. That is not the same as an established safe pattern. There is no known threshold, and risk scales with frequency and cumulative dose.

The honest position

MDMA neurotoxicity gets argued over. This one does not: thousands of patients, confirmed on biopsy, staged on imaging. K-cramps are not something to push through, they are a measurable sign of tissue being damaged while you feel them. Early is reversible, and the reason people lose bladders is that they push through the cramps for months first.

For effects, doses and safer use, see our ketamine harm reduction guide. If you are combining substances, our drug interaction checker covers what adds further risk.

Sources

Shahani 2007 case series PMID 17482909 | 2008 Hong Kong 59-patient series PMID 18680495 | 2015 pathophysiology review PMID 26087832 | 2022 review, 3-4 fold risk PMID 36118982 | 2022 meta-analysis, 45 studies PMID 36464318 | 2024 therapeutic-ketamine case report PMID 38166893 | bladder reconstruction series PMID 23996856